These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 34173985)
1. Multidose pharmacokinetics and safety of a modified, compounded theophylline product in dogs. Reinhart JM; Perkowski C; Lester C; Campos V; Kadotani S; Li Z; McKiernan BC; Fries R J Vet Pharmacol Ther; 2021 Nov; 44(6):902-909. PubMed ID: 34173985 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of a modified, compounded theophylline product in dogs. Cavett CL; Li Z; McKiernan BC; Reinhart JM J Vet Pharmacol Ther; 2019 Nov; 42(6):593-601. PubMed ID: 31529628 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of a 503B outsourcing facility-produced theophylline in dogs. Reinhart JM; de Oliveira GAR; Forsythe L; Li Z PLoS One; 2022; 17(1):e0262336. PubMed ID: 34990472 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the bioavailability and pharmacokinetics of two extended-release theophylline formulations in dogs. Bach JE; Kukanich B; Papich MG; McKiernan BC J Am Vet Med Assoc; 2004 Apr; 224(7):1113-9. PubMed ID: 15074856 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic studies of theophylline in dogs. McKiernan BC; Neff-Davis CA; Koritz GD; Davis LE; Pheris DR J Vet Pharmacol Ther; 1981 Jun; 4(2):103-10. PubMed ID: 7349323 [TBL] [Abstract][Full Text] [Related]
6. A retrospective study of theophylline-based therapy with tracheal collapse in small-breed dogs: 47 cases (2013-2017). Jeung SY; Sohn SJ; An JH; Chae HK; Li Q; Choi M; Yoon J; Song WJ; Youn HY J Vet Sci; 2019 Sep; 20(5):e57. PubMed ID: 31565900 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of total thyroxine after repeated oral administration of levothyroxine solution and its clinical efficacy in hypothyroid dogs. van Dijl IC; Le Traon G; van de Meulengraaf BD; Burgaud S; Horspool LJ; Kooistra HS J Vet Intern Med; 2014; 28(4):1229-34. PubMed ID: 24773132 [TBL] [Abstract][Full Text] [Related]
8. Effect of caffeine on circulating theophylline levels in beagle dogs. Tse FL; Valia KH; Szeto DW; Raimondo TJ; Koplowitz B J Pharm Sci; 1981 Apr; 70(4):395-9. PubMed ID: 7229951 [TBL] [Abstract][Full Text] [Related]
9. Enrofloxacin-theophylline interaction: influence of enrofloxacin on theophylline steady-state pharmacokinetics in the beagle dog. Intorre L; Mengozzi G; Maccheroni M; Bertini S; Soldani G J Vet Pharmacol Ther; 1995 Oct; 18(5):352-6. PubMed ID: 8587153 [TBL] [Abstract][Full Text] [Related]
11. Theophylline pharmacokinetics following single and repeated administration of slow-release capsules. Torrent J; Izquierdo I; Barbanoj MJ; Obach R; Nomen M; Jane F Eur J Drug Metab Pharmacokinet; 1988; 13(4):225-30. PubMed ID: 3243316 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic study of theophylline in dogs after intravenous administration with and without ethylenediamine. Kawai H; Kokubun S; Matsumoto T; Kojima J; Onodera K Methods Find Exp Clin Pharmacol; 2000 Apr; 22(3):179-84. PubMed ID: 10893702 [TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics of theophylline during co-treatment with ticarcillin plus clavulanic acid in patients suffering from acute exacerbation of chronic bronchitis. Matera MG; Cazzola M; Lampa E; Santangelo G; Paizis G; Vinciguerra A; Rossi F J Chemother; 1993 Aug; 5(4):233-6. PubMed ID: 8229151 [TBL] [Abstract][Full Text] [Related]
15. Canine chronic bronchitis. Rozanski E Vet Clin North Am Small Anim Pract; 2014 Jan; 44(1):107-16. PubMed ID: 24268336 [TBL] [Abstract][Full Text] [Related]
16. Bioequivalence of orally administered generic, compounded, and innovator-formulated itraconazole in healthy dogs. Mawby DI; Whittemore JC; Genger S; Papich MG J Vet Intern Med; 2014; 28(1):72-7. PubMed ID: 24428315 [TBL] [Abstract][Full Text] [Related]
18. Effects of fenugreek, garden cress, and black seed on theophylline pharmacokinetics in beagle dogs. Al-Jenoobi FI; Ahad A; Mahrous GM; Al-Mohizea AM; AlKharfy KM; Al-Suwayeh SA Pharm Biol; 2015 Feb; 53(2):296-300. PubMed ID: 25243874 [TBL] [Abstract][Full Text] [Related]
19. No pharmacokinetic or pharmacodynamic interaction between theophylline and the leukotriene biosynthesis inhibitor BAY x 1005. Groen H; Moesker HL; Leeuwenkamp OR; Sollie FA; Jonkman JH J Clin Pharmacol; 1996 Jul; 36(7):639-46. PubMed ID: 8844447 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and clinical effects in dogs of a sustained-release formulation of theophylline. McKellar QA Vet Rec; 1993 Aug; 133(6):133-6. PubMed ID: 8236689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]